Recent News

398 News Items found
SKI immunologist Gretchen Diehl
A Delicate Balance: Learning New Ways That Gut Microbes Educate the Immune System
Researchers at the Sloan Kettering Institute have found that gut microbes shape the immune system of mice in an unexpected way.
In the Lab
MSK computational biologists Christina Leslie and Yuri Pritykin
Computational Biologists Assemble Atlas of T Cell Dysfunction
The tool will aid basic and translational researchers interested in understanding why immune cells stop working.
Researchers Gary Dixon (on TV monitor), Heng Pan, Olivier Elemento, and Danwei Huangfu in the lab
Stem Cell Research Unlocks a New Discovery about Controlling Genes
Sloan Kettering Institute scientists report new findings about a gene that helps regulate DNA methylation.
Sloan Kettering Institute molecular biologist Scott Keeney
A ‘Breaking’ Breakthrough: Researchers at the Sloan Kettering Institute Discovery How DNA Breaks Are Controlled During Meiosis
The DNA breaks that occur during meiosis are necessary but dangerous. Scientists now have a better handle on how cells control the chaos.
SKI Developmental Biology Program Chair Kat Hadjantonakis
2nd Annual Kravis Woman in Science Endeavor Symposium Held at Memorial Sloan Kettering
The event featured scientific talks from leading women in science, including winners of this year’s Kravis WiSE fellowships.
MSK molecular biologist Agnel Sfeir
Exploring the ‘Forgotten Genome’ and More: At Work with Molecular Biologist Agnel Sfeir
Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.
Developmental biologist Kathryn Anderson
In Memoriam: Developmental Biologist Kathryn V. Anderson
Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute.
Roberta Zappasodi, Taha Merghoub, and Jedd Wolchok. Photo credit: Flynn Larsen for Ludwig Cancer Research
To Improve Immunotherapy, Researchers Look to Shift Immune Cells’ Access to Sugar
More sugar available for immune cells could mean better immune responses against cancer.
Hans-Guido Wendel
Tree-Derived Cancer Drug Shows Promise in Treating COVID-19 Virus
Originally explored as a cancer drug, the tree-derived chemical is now being mined for its antiviral properties.
In the Lab
Physician-scientist Alex Kentsis
Research Shows How Common Feature of Blood Cancers Can Be Targeted
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.